Cetylpyridinium chloride

Generic Name
Cetylpyridinium chloride
Brand Names
Cepacol Antibacterial Mouthwash, Crest Mouthwash, Orajel Bleeding Gum Rinse, Orasep Reformulated Dec 2013
Drug Type
Small Molecule
Chemical Formula
C21H38N
CAS Number
7773-52-6
Unique Ingredient Identifier
CUB7JI0JV3
Background

Cetylpyridinium is a quaternary ammonium with broad-spectrum antiseptic properties. Its salt form, cetylpyridinium chloride, is typically found as an active ingredient in mouthwashes, toothpastes, lozenges, throat sprays, breath sprays, and nasal sprays. In these products, it generally mediates an antiseptic activity and protective action against dental plaq...

Indication

Typically employed as the cetylpyridinium chloride salt, this compound is commonly used as an active ingredient in various over-the-counter mouthwashes, toothpastes, lozenges, and mouth sprays where it is generally indicated for antiseptic actions, gingivitis and plaque prevention, as well as action or prevention against some other oropharyngeal bacterial in...

Associated Conditions
Gingivitis, Oral Pain, Pain, Orofacial, Sore Throat, Stomatitis, Teething pain, Throat irritation, Dry cough, Gum pain, Oral discomfort and pain, Oral infections, Pain in throat, Throat infections, Throat inflammation
Associated Therapies
Disinfection, Oral antisepsis, Oral disinfection

Feasibility and Acceptability of Use of Daily Oral Rinse in Pregnant Women in Rural Nepal

First Posted Date
2016-06-02
Last Posted Date
2017-02-23
Lead Sponsor
Johns Hopkins Bloomberg School of Public Health
Target Recruit Count
175
Registration Number
NCT02788786
Locations
🇳🇵

Nepal Nutrition Intervention Project, Hariaun, Sarlahi District, Nepal

Preventive Effects of Cetylpyridinium Chloride on SarcopeniaStudy

Early Phase 1
Completed
Conditions
Interventions
First Posted Date
2014-11-21
Last Posted Date
2021-03-29
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
65
Registration Number
NCT02297997

Safety Dermatological Evaluation: Acceptability With Odontological Follow up - Cepacol Teen.

Phase 3
Completed
Conditions
Interventions
First Posted Date
2008-08-07
Last Posted Date
2009-03-04
Lead Sponsor
Sanofi
Target Recruit Count
31
Registration Number
NCT00729599
Locations
🇧🇷

Sanofi-aventis, São Paulo, Brazil

Safety Oral Mucosa Evaluation - Acceptability With Odontological Follow up - Cepacol Canela Power

Phase 3
Completed
Conditions
Interventions
First Posted Date
2008-05-30
Last Posted Date
2009-02-13
Lead Sponsor
Sanofi
Target Recruit Count
30
Registration Number
NCT00687037
Locations
🇧🇷

Sanofi-aventis, São Paulo, Brazil

© Copyright 2024. All Rights Reserved by MedPath